Protara Therapeutics, Inc.
TARA
26 insider filings · Latest: Jun 29, 2026
Common Stock Transactions
| Txn Date | Accepted | Insider | Type | Shares | Avg Price | Value | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|---|
| Jun 29, 2026 | Jul 1 8:10 PM | Jesse SheffermanDirector, CEO and President | Sale | 215,687 | $4.09 | $882.2K | 721,832(D) | View → |
| Jun 29, 2026 | Jun 29 8:52 PM | JESSE SHEFFERMAN | Proposed Sale | 215,687 | $4.09 | $882.0K | — | View → |
| Apr 23, 2026 | Apr 24 12:42 AM | Baker Brothers Life Sciences, L.P. | Proposed Sale | 300,176 | $5.35 | $1.6M | — | View → |
| Apr 23, 2026 | Apr 24 12:41 AM | 667, L.P. | Proposed Sale | 24,802 | $5.35 | $132.7K | — | View → |
| Apr 8, 2026 | Apr 9 9:25 PM | Jacqueline ZummoChief R&D Officer | Sale | 1,134 | $5.40 | $6.1K | 94,827(D) | View → |
| Apr 1, 2026 | Apr 2 8:05 PM | Jacqueline ZummoChief R&D Officer | Sale | 22,598 | $5.26 | $118.9K | 95,961(D) | View → |
| Apr 1, 2026 | Apr 1 2:32 PM | Zummo Jacqueline | Proposed Sale | 23,732 | $5.26 | $124.8K | — | View → |
| Mar 6, 2026 | Mar 6 10:51 PM | 667, L.P. | Proposed Sale | 38,277 | $5.85 | $223.9K | — | View → |
| Mar 6, 2026 | Mar 6 10:50 PM | Baker Brothers Life Sciences, L.P. | Proposed Sale | 461,723 | $5.85 | $2.7M | — | View → |
| Mar 4, 2026 | Mar 5 1:37 AM | 667, L.P. | Proposed Sale | 35,173 | $6.26 | $220.2K | — | View → |
| Mar 4, 2026 | Mar 5 1:35 AM | Baker Brothers Life Sciences, L.P. | Proposed Sale | 424,125 | $6.26 | $2.7M | — | View → |
| Feb 25, 2026 | Feb 26 12:58 AM | 667, L.P. | Proposed Sale | 78,716 | $5.81 | $457.0K | — | View → |
| Feb 25, 2026 | Feb 26 12:57 AM | Baker Brothers Life Sciences, L.P. | Proposed Sale | 947,479 | $5.81 | $5.5M | — | View → |
| Feb 24, 2026 | Feb 25 2:13 AM | 667, L.P. | Proposed Sale | 26,755 | $6.04 | $161.6K | — | View → |
| Feb 24, 2026 | Feb 25 2:11 AM | Baker Brothers Life Sciences, L.P. | Proposed Sale | 322,039 | $6.04 | $1.9M | — | View → |
| Mar 26, 2025 | Mar 26 3:17 PM | Zummo Jacqueline | Proposed Sale | 21,224 | $4.55 | $96.6K | — | View → |
Stock Options & Derivatives
| Txn Date | Accepted | Insider | Type | Shares | Exercise Price | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|
| Jun 29, 2026 | Jul 1 8:10 PM | Jesse SheffermanDirector, CEO and President | Option Exercise | 215,687 | $1.91 | 141,313(D) | View → |
| Jun 15, 2026 | Jun 16 8:05 PM | Richard S LevyDirector | Grant/Award | 31,000 | $3.94 | 31,000(D) | View → |
| Jun 15, 2026 | Jun 16 8:05 PM | Michael Edward SolomonDirector | Grant/Award | 31,000 | $3.94 | 31,000(D) | View → |
| Jun 15, 2026 | Jun 16 8:05 PM | Cynthia SmithDirector | Grant/Award | 31,000 | $3.94 | 31,000(D) | View → |
| Jun 15, 2026 | Jun 16 8:05 PM | Gregory SargenDirector | Grant/Award | 31,000 | $3.94 | 31,000(D) | View → |
| Jun 15, 2026 | Jun 16 8:05 PM | Jane HuangDirector | Grant/Award | 31,000 | $3.94 | 31,000(D) | View → |
| Jun 15, 2026 | Jun 16 8:05 PM | Roger GarceauDirector | Grant/Award | 31,000 | $3.94 | 31,000(D) | View → |
| Jun 15, 2026 | Jun 16 8:05 PM | Barry P FlannellyDirector | Grant/Award | 31,000 | $3.94 | 31,000(D) | View → |
| Jun 15, 2026 | Jun 16 8:05 PM | Luke M BesharDirector | Grant/Award | 31,000 | $3.94 | 31,000(D) | View → |
| Jan 16, 2026 | Jan 21 9:37 PM | William ConklingChief Commercial Officer | Grant/Award | 158,000 | $5.01 | 158,000(D) | View → |
| Jan 16, 2026 | Jan 21 9:37 PM | Patrick FabbioChief Financial Officer | Grant/Award | 175,000 | $5.01 | 175,000(D) | View → |
| Jan 16, 2026 | Jan 21 9:36 PM | Hannah FryVP, Controller | Grant/Award | 55,000 | $5.01 | 55,000(D) | View → |
| Jan 16, 2026 | Jan 21 9:36 PM | Leonardo Viana NicacioChief Medical Officer | Grant/Award | 158,000 | $5.01 | 158,000(D) | View → |
| Jan 16, 2026 | Jan 21 9:36 PM | Jesse SheffermanDirector, CEO and President | Grant/Award | 524,000 | $5.01 | 524,000(D) | View → |
| Jan 16, 2026 | Jan 21 9:36 PM | Jacqueline ZummoChf Scientific Operations Off | Grant/Award | 180,000 | $5.01 | 180,000(D) | View → |